These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32443954)

  • 1. Knowledge and Practice of Harm Reduction Strategies Among People Who Report Frequent Cannabis Use.
    Kruger JS; Kruger D; Collins RL
    Health Promot Pract; 2021 Jan; 22(1):24-30. PubMed ID: 32443954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis Enthusiasts' Knowledge of Medical Treatment Effectiveness and Increased Risks From Cannabis Use.
    Kruger DJ; Kruger JS; Collins RL
    Am J Health Promot; 2020 May; 34(4):436-439. PubMed ID: 31916839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences of marijuana-vaporizer users.
    Malouff JM; Rooke SE; Copeland J
    Subst Abus; 2014; 35(2):127-8. PubMed ID: 24821347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weeding out the information: an ethnographic approach to exploring how young people make sense of the evidence on cannabis.
    Moffat BM; Jenkins EK; Johnson JL
    Harm Reduct J; 2013 Nov; 10():34. PubMed ID: 24279829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harm reduction and cannabis social clubs: Exploring their true potential.
    Obradors-Pineda A; Bouso JC; Parés-Franquero Ò; Romaní JO
    Int J Drug Policy; 2021 Nov; 97():103358. PubMed ID: 34252786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Health Care Providers' Knowledge of Medical Cannabis.
    Kruger DJ; Mokbel MA; Clauw DJ; Boehnke KF
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):501-507. PubMed ID: 34463161
    [No Abstract]   [Full Text] [Related]  

  • 7. Responsible and controlled use: Older cannabis users and harm reduction.
    Lau N; Sales P; Averill S; Murphy F; Sato SO; Murphy S
    Int J Drug Policy; 2015 Aug; 26(8):709-18. PubMed ID: 25911027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for a feasibility study investigating the UCalgary's
    Mader J; Smith JM; Smith J; Christensen DR
    BMJ Open; 2020 Feb; 10(2):e032651. PubMed ID: 32051305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International differences in patterns of cannabis use among youth: Prevalence, perceptions of harm, and driving under the influence in Canada, England & United States.
    Wadsworth E; Hammond D
    Addict Behav; 2019 Mar; 90():171-175. PubMed ID: 30412908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction for cannabis: Factor analysis of a protective behavioral strategies survey.
    Caffrey KS; Wright BR; Maarhuis PL
    J Am Coll Health; 2018 Apr; 66(3):194-201. PubMed ID: 29405859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond deficit and harm reduction: Incorporating the spectrum of wellness as an interpretive framework for cannabis consumption.
    Subritzky T
    Int J Drug Policy; 2018 Oct; 60():18-23. PubMed ID: 30086481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "If I knew I could get that every hour instead of alcohol, I would take the cannabis": need and feasibility of cannabis substitution implementation in Canadian managed alcohol programs.
    Pauly B; Brown M; Chow C; Wettlaufer A; ; Graham B; Urbanoski K; Callaghan R; Rose C; Jordan M; Stockwell T; Thomas G; Sutherland C
    Harm Reduct J; 2021 Jun; 18(1):65. PubMed ID: 34162375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goal commitment predicts cannabis use for adolescents in treatment.
    Kaminer Y; Ohannessian CM; Burke RH
    Subst Abus; 2019; 40(4):496-500. PubMed ID: 30810498
    [No Abstract]   [Full Text] [Related]  

  • 14. Qualitative research in Spanish cannabis social clubs: "The moment you enter the door, you are minimising the risks".
    Belackova V; Tomkova A; Zabransky T
    Int J Drug Policy; 2016 Aug; 34():49-57. PubMed ID: 27461986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes.
    Cortellini A; Porzio G; Cofini V; Necozione S; Giusti R; Marchetti P; Aloe Spiriti MA; Costanzi A; Peris F; Ravoni G; Spinelli G; Ficorella C; Verna L
    J Oncol Pharm Pract; 2019 Sep; 25(6):1439-1444. PubMed ID: 31042135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.
    Thornton LK; Baker AL; Johnson MP; Lewin T
    Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cross-sectional Survey of Health Professionals' Attitudes toward Medicinal Cannabis Use as Part of Cancer Management.
    Hewa-Gamage D; Blaschke S; Drosdowsky A; Koproski T; Braun A; Ellen S
    J Law Med; 2019 Jul; 26(4):815-824. PubMed ID: 31682359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' Attitudes and Practices Regarding Cannabis and Recommending Medical Cannabis Use.
    Kruger DJ; Gerlach J; Kruger JS; Mokbel MA; Clauw DJ; Boehnke KF
    Cannabis Cannabinoid Res; 2024 Aug; 9(4):e1048-e1055. PubMed ID: 37098170
    [No Abstract]   [Full Text] [Related]  

  • 19. Public stigma in health and non-healthcare students: attributions, emotions and willingness to help with adolescent self-harm.
    Law GU; Rostill-Brookes H; Goodman D
    Int J Nurs Stud; 2009 Jan; 46(1):107-18. PubMed ID: 18962601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists.
    Szaflarski M; McGoldrick P; Currens L; Blodgett D; Land H; Szaflarski JP; Segal E
    Epilepsy Behav; 2020 Aug; 109():107102. PubMed ID: 32442891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.